U.S. Markets closed

Varian Medical Systems, Inc. (VAR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
174.11-0.01 (-0.01%)
At close: 4:03PM EST

Varian Medical Systems, Inc.

3100 Hansen Way
Palo Alto, CA 94304
United States
650 493 4000
http://www.varian.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees10,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Dow R. WilsonCEO & Director2.45M6.38M1959
Mr. Christopher A. TothPres & COO972.98k1.03M1979
Ms. Kolleen T. KennedyChief Growth Officer & Pres of Proton Solutions1.45M4.48M1959
Mr. Jesse Michael BruffSr. VP of Fin. & CFON/AN/A1969
Mr. Magnus A. MomsenSr. VP, Chief Accounting Officer & Corp. ControllerN/AN/AN/A
Mr. Thomas RoddenSr. VP & Chief Information OfficerN/AN/AN/A
Mr. Anshul MaheshwariVP of Investor Relations & TreasurerN/AN/AN/A
Ms. Vy H. TranChief Compliance Officer and Sr. VP of Regulatory Affairs & Quality AssuranceN/AN/A1973
Mr. Michael D. HutchinsonSr. VP, Chief Legal Officer & Corp. Sec.N/AN/A1971
Mr. Mark PlungyDirector of PRN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.

Corporate Governance

Varian Medical Systems, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.